Oklahoma State University   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Stillwater OK United States (1890)

Organization Overview

First Clinical Trial
2007
NCT00473642
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Arpita Basu | Okklahoma State University | Oklahoma State University | Oklahoma State University Center for Health Sciences | Oklahoma State University Medical Center

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Choroidal Neovascularization (Phase 4)

Heart Failure (Phase 2)

HIV Infections (Phase 4)

Macular Degeneration (Phase 4)

Neovascularization, Pathologic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 11
  • # of Trial APIs: 14